EE71 Cost-Effectiveness Analysis of Using Foundationone Liquid CDx in Patients With Advanced Non-Small Cell Lung Cancer in Whom Tissue-Based Testing Is Not Feasible
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.343
https://www.valueinhealthjournal.com/article/S1098-3015(23)03473-3/fulltext
Title :
EE71 Cost-Effectiveness Analysis of Using Foundationone Liquid CDx in Patients With Advanced Non-Small Cell Lung Cancer in Whom Tissue-Based Testing Is Not Feasible
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03473-3&doi=10.1016/j.jval.2023.09.343
First page :
Section Title :
Open access? :
No
Section Order :
12367